Abetalipoproteinemia in Israel: Evidence for a founder mutation in the Ashkenazi Jewish population and a contiguous gene deletion in an Arab patient

被引:26
|
作者
Benayoun, Liat
Granot, Esther
Rizel, Leah
Allon-Shalev, Stavit
Behar, Doron M.
Ben-Yosef, Tamar [1 ]
机构
[1] Technion Israel Inst Technol, Dept Genet, Haifa, Israel
[2] Technion Israel Inst Technol, Fac Med, Rappaport Family Inst Res Med Sci, Haifa, Israel
[3] Ha Emek Med Ctr, Genet Inst, Afula, Israel
[4] Kaplan Med Ctr, Div Pediat, Rehovot, Israel
[5] Mol Med Lab, Haifa, Israel
关键词
abetalipoproteinemia; microsomal triglyceride transfer protein; MTP; Ashkenazi Jews; contiguous gene deletion;
D O I
10.1016/j.ymgme.2006.12.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Abetalipoproteinemia (ABL) is a rare autosomal recessive metabolic disorder, characterized by the absence of plasma apolipoprotein B-containing lipoproteins and very low levels of plasma triglycerides and cholesterol. ABL is caused by mutations of the MTP gene. We investigated the genetic basis for ABL in a cohort of Israeli families. In Ashkenazi Jewish patients we identified a conserved haplotype and a common MTP mutation, p.G865X, with a carrier frequency of 1: 131 in this population. We also report the first case of ABL and additional abnormalities in a Muslim Arab patient, due to a homozygous contiguous gene deletion of approximately 481 kb, including MTP and eight other genes. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:453 / 457
页数:5
相关论文
共 33 条
  • [1] A founder mutation in the TCIRG1 gene causes osteopetrosis in the Ashkenazi Jewish population
    Anderson, S. L.
    Jalas, C.
    Fedick, A.
    Reid, K. F.
    Carpenter, T. O.
    Chirnomas, D.
    Treff, N. R.
    Ekstein, J.
    Rubin, B. Y.
    CLINICAL GENETICS, 2015, 88 (01) : 74 - 79
  • [2] A founder mutation in the MPL gene causes congenital amegakaryocytic thrombocytopenia (CAMT) in the Ashkenazi Jewish population
    Jalas, Chaim
    Anderson, Sylvia L.
    Laufer, Tova
    Martimucci, Kristina
    Bulanov, Alex
    Xie, Xie
    Ekstein, Josef
    Rubin, Berish Y.
    BLOOD CELLS MOLECULES AND DISEASES, 2011, 47 (01) : 79 - 83
  • [3] Nemaline myopathy in the Ashkenazi Jewish population is caused by a deletion in the nebulin gene
    Sylvia L. Anderson
    Josef Ekstein
    Mary C. Donnelly
    Erin M. Keefe
    Nicole R. Toto
    Lauretta A. LeVoci
    Berish Y. Rubin
    Human Genetics, 2004, 115 : 185 - 190
  • [4] Nemaline myopathy in the Ashkenazi Jewish population is caused by a deletion in the nebulin gene
    Anderson, SL
    Ekstein, J
    Donnelly, MC
    Keefe, EM
    Toto, NR
    LeVoci, LA
    Rubin, BY
    HUMAN GENETICS, 2004, 115 (03) : 185 - 190
  • [5] Leukoencephalopathy and early death associated with an Ashkenazi-Jewish founder mutation in the Hikeshi gene
    Edvardson, Simon
    Kose, Shingo
    Jalas, Chaim
    Fattal-Valevski, Aviva
    Watanabe, Ai
    Ogawa, Yutaka
    Mamada, Hiroshi
    Fedick, Anastasia M.
    Ben-Shachar, Shay
    Treff, Nathan R.
    Shaag, Avraham
    Bale, Sherri
    Gaertner, Jutta
    Imamoto, Naoko
    Elpeleg, Orly
    JOURNAL OF MEDICAL GENETICS, 2016, 53 (02) : 132 - 137
  • [6] A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations
    Gallione, Carol J.
    Solatycki, Ann
    Awad, Issam A.
    Weber, James L.
    Marchuk, Douglas A.
    GENETICS IN MEDICINE, 2011, 13 (07) : 662 - 666
  • [7] A founder mutation in COL4A3 causes autosomal recessive Alport syndrome in the Ashkenazi Jewish population
    Webb, B. D.
    Brandt, T.
    Liu, L.
    Jalas, C.
    Liao, J.
    Fedick, A.
    Linderman, M. D.
    Diaz, G. A.
    Kornreich, R.
    Trachtman, H.
    Mehta, L.
    Edelmann, L.
    CLINICAL GENETICS, 2014, 86 (02) : 155 - 160
  • [8] Evidence that founder effect of the Ashkenazi mutation in Bloom's syndrome predates Jewish migration to Eastern Europe.
    German, J
    Ciocci, S
    Proytcheva, M
    Ye, T
    Ellis, NA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A199 - A199
  • [9] Maple syrup urine disease: Identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population
    Edelmann, L
    Wasserstein, MP
    Kornreich, R
    Sansaricq, C
    Snyderman, SE
    Diaz, GA
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 863 - 868
  • [10] HAPLOTYPE ANALYSIS OF POLYMORPHIC MARKERS SURROUNDING THE FANCONI-ANEMIA GENE FAC - EVIDENCE FOR A FOUNDER EFFECT FOR THE IVS4 +4 A-]T MUTATION IN THE ASHKENAZI JEWISH POPULATION
    VERLANDER, PC
    SHIN, HT
    AUERBACH, AD
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 992 - 992